We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





MEDICA 2021 + COMPAMED 2021 Re-Launches In-Person with Innovations Galore for Outpatient and Inpatient Care

By LabMedica International staff writers
Posted on 15 Nov 2021
The world's leading medical trade fair MEDICA and the international trade fair for suppliers to the medical technology industry, COMPAMED, returned to the Düsseldorf exhibition halls in Germany this year from 15 to 18 November 2021 in a presence format.

MEDICA’s 2,900 exhibitors and COMPAMED’s 490 exhibitors arrived from a total of 70 countries at the in-person events. More...
Exhibitors brought their comprehensive portfolios of medical products, devices and instruments, including all the stages in their development, production and distribution processes, to present at MEDICA 2021 and COMPAMED 2021. The themed segments of MEDICA were based around meeting the entire range of needs for inpatient and outpatient care.

The MEDICA segments included: Lab technology & diagnostics, electrotherapy and medical technology, disposables and consumables, information and communication technology (digital health) and physiotherapy and orthopedic technology. The exhibitors at COMPAMED showcased the entire range of products and services that the supplier market provides for medical technology: from individual components and parts, along with innovative materials, to packaging solutions and high-tech processes such as additive manufacturing or complete contract manufacturing.

The significant industry trends and themes, such as an increased demand for digital healthcare solutions or the challenges that service providers face in conjunction with the new EU Medical Device Regulation (MDR), were reflected in the range of products and services that the exhibitors offered and also in the program of the forums and accompanying conferences that were integrated into the trade fairs. In line with the hybrid event concept, the lectures, discussions and award ceremonies for many of these program features could be followed either on-site at the forums’ stages in the trade fair halls or online via a live stream, accessible via the industry portals MEDICA.de and COMPAMED.de, depending upon the preferences of the ticket holder. Further highlights of MEDICA 2021’s program included the 44th German Hospital Conference (as a live stream) and the English language conferences DiMiMED and MEDICA MEDICINE + SPORTS CONFERENCE. These conferences gathered together experts in the fields of military and disaster medicine and in sports medicine and science at the venue in Düsseldorf.

The countries that generally asked for the largest areas before the pandemic were, once again, represented in full force at MEDICA. Italy, South Korea, Turkey, the US and other European nations, such as France, Spain, Great Britain and Poland, were all high on the list behind Germany. After Germany with around 550 exhibitors (MEDICA + COMPAMED), there was a particularly large number of companies from North America. More than 300 exhibitors presented their latest medical technology and medical product solutions to trade visitors from all sectors of the healthcare industry. In addition to the individual exhibitors, North American suppliers also participated in three US and one Canadian pavilion, which were supported by the respective government agencies. Canada's joint stand featured four of the 13 Canadian companies at MEDICA. Of the 223 US companies at MEDICA, 105 exhibited in the two US pavilions in Halls 3 (diagnostic equipment) and 16 (laboratory equipment), while 13 of the 63 US exhibitors at COMPAMED participated in the US pavilion in Hall 14.

"It is pleasant surprise to see such optimism throughout the industry. The broad consensus is that nothing can replace the valuable face-to-face exchanges that international trade shows like MEDICA and COMPAMED provide, said yan Klemm, Senior Business Development Manager at Messe Düsseldorf North America.



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Clostridium Difficile Test
Immunocard Toxins A&B
New
Blood Gas and Chemistry Analysis System
Edan i500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.